First 3 runs free, then $50/run
    First 3 runs free, then $50/run

    Investment case

    Health Catalyst, Inc.

    HCAT · 3 developments mapped · last assessed 2026-09-15

    Market Ontology has mapped 3 macro, policy, and market developments to Health Catalyst, Inc. since 2026-09-15. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.

    Last close
    Unavailable
    No published quote
    Market cap
    Unavailable
    Equity value
    Diluted shares
    Unavailable
    Latest reported
    Sector
    Unavailable
    Listing
    Unavailable
    Filings
    Unavailable
    No published filing

    Valuation

    No validated run has been published for HCAT yet, so no modelled value is shown. The HCAT valuation is in the public catch-up queue.

    Subscribers do not wait for the weekly cycle: they run HCAT on demand, against live prices and the latest filings, and change any assumption the developments below move.

    Filed financials

    A validated filed-statement snapshot has not been published for HCAT. Missing data is not estimated or replaced with scenario assumptions.

    Current case

    • Open question

      Health Catalyst Appoints Simeon Kohl as CEO with 2.75M RSU Inducement Grant

      Leadership change, potential strategic shift, and share dilution from RSU grant.

      · Moves future growth rate, management effectiveness, cost structure efficiency

    What changed, by assumption

    Future growth rate
    • 2026-09-15Health Catalyst Appoints Simeon Kohl as CEO with 2.75M RSU Inducement Grant
    • 2026-09-15Health Catalyst appoints Simeon Kohl as CEO with 2.75M share inducement award
    • 2026-09-15Health Catalyst Appoints Simeon Kohl CEO With 2.75M Inducement Share Grant

    Event impact log

    Full ledger →
    DateMechanismDirectionHorizonImpact
    2026-09-15Health Catalyst Appoints Simeon Kohl as CEO with 2.75M RSU Inducement Grantmixed1-3m0.60
    2026-09-15Health Catalyst appoints Simeon Kohl as CEO with 2.75M share inducement awardmixed1-3m0.60
    2026-09-15Health Catalyst Appoints Simeon Kohl CEO With 2.75M Inducement Share Grantmixed1-3m0.60